PRIME FOCUS
|
PRIME FOCUS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 2.82 | -12.57 | -13.49 | 4.92 | -5.73 |
| CEPS(Rs) | 12.36 | 1.57 | 0.33 | 22.08 | 8.11 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 23.64 | 18.66 | 11.06 | -8.85 | -5.06 |
| Tax Rate(%) | 9.83 | -11.58 | 16.74 | 36.47 | -111.37 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 30.44 | 21.84 | 6.40 | 20.97 | 23.53 |
| EBIT Margin(%) | 18.15 | 3.53 | -0.73 | 15.84 | 8.60 |
| Pre Tax Margin(%) | 7.15 | -11.41 | -14.85 | 6.59 | -2.43 |
| PAT Margin (%) | 6.45 | -12.73 | -12.37 | 4.19 | -5.14 |
| Cash Profit Margin (%) | 20.51 | 1.31 | 0.25 | 14.24 | 7.18 |
| Performance Ratios | |||||
| ROA(%) | 3.21 | -5.99 | -7.14 | 3.16 | -3.21 |
| ROE(%) | 25.17 | -102.82 | -1,469.14 | - | - |
| ROCE(%) | 14.29 | 2.74 | -0.69 | 20.76 | 9.36 |
| Asset Turnover(x) | 0.50 | 0.47 | 0.58 | 0.75 | 0.62 |
| Sales/Fixed Asset(x) | 0.57 | 0.51 | 0.61 | 0.77 | 0.61 |
| Working Capital/Sales(x) | -2.15 | -2.16 | 5.08 | 6.84 | -2.16 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.74 | 1.97 | 1.63 | 1.29 | 1.63 |
| Receivable days | 34.37 | 41.27 | 47.10 | 42.25 | 36.19 |
| Inventory Days | - | - | - | - | - |
| Payable days | - | - | - | - | - |
| Valuation Parameters | |||||
| PER(x) | 116.89 | - | - | 16.54 | - |
| PCE(x) | 26.66 | 57.82 | 298.58 | 3.69 | 11.23 |
| Price/Book(x) | 13.94 | 4.86 | 8.88 | -9.19 | -18.01 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 6.38 | 1.83 | 1.70 | 1.33 | 1.64 |
| EV/Core EBITDA(x) | 19.48 | 6.51 | 14.34 | 4.88 | 6.25 |
| EV/EBIT(x) | 35.13 | 51.87 | -233.77 | 8.38 | 19.07 |
| EV/CE(x) | 4.24 | 1.36 | 1.51 | 1.58 | 1.75 |
| M Cap / Sales | 5.47 | 0.76 | 0.75 | 0.52 | 0.81 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 29.92 | -8.90 | -14.94 | 37.16 | 33.49 |
| Core EBITDA Growth(%) | 51.18 | 115.67 | -62.80 | 42.08 | 34.02 |
| EBIT Growth(%) | 567.41 | 541.60 | -103.92 | 152.72 | 33.32 |
| PAT Growth(%) | 165.77 | 6.18 | -351.16 | 211.85 | -209.74 |
| EPS Growth(%) | 122.42 | 6.84 | -374.38 | 185.85 | -294.93 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 2.69 | 7.31 | 11.85 | -14.65 | -20.21 |
| Current Ratio(x) | 0.70 | 0.67 | 1.33 | 1.41 | 0.54 |
| Quick Ratio(x) | 0.70 | 0.67 | 1.33 | 1.41 | 0.54 |
| Interest Cover(x) | 1.65 | 0.24 | -0.05 | 1.71 | 0.78 |
| Total Debt/Mcap(x) | 0.19 | 1.51 | 1.33 | 1.59 | 1.12 |
Compare Financial Ratios of peers of PRIME FOCUS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PRIME FOCUS | ₹21,226.2 Cr | -6% | -23.8% | 60.3% | Stock Analytics | |
| SAGILITY | ₹20,644.7 Cr | -2.5% | -3.1% | -0.7% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹16,521.5 Cr | 16.9% | 16.9% | 3% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹14,810.6 Cr | -5.1% | -2.9% | -41.9% | Stock Analytics | |
| INDEGENE | ₹13,772.2 Cr | -4.5% | -3.6% | 9.1% | Stock Analytics | |
| NESCO | ₹6,929.0 Cr | -6.5% | -8% | -25.9% | Stock Analytics | |
PRIME FOCUS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PRIME FOCUS | -6% |
-23.8% |
60.3% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses
